Johnson & Johnson SPINE,SPORTS & OTHER — % Change remained flat by 0.0% to -0.7% in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 122.6%, from 2.9% to -0.7%. Over 3 years (FY 2021 to FY 2024), SPINE,SPORTS & OTHER — % Change shows an upward trend with a -61.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
A positive percentage indicates organic or inorganic growth in the segment, while a negative percentage suggests a contraction in market demand or loss of competitive advantage. Consistent positive growth relative to the broader medical device market suggests strong product innovation and sales execution.
This metric measures the period-over-period percentage growth or decline in net sales for the spine, sports medicine, an...
Comparable to organic or reported revenue growth rates for specific business units within diversified healthcare and medical technology peers.
jnj_segment_spine_sports_other_change| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | -46.5% | 24.1% | 11.5% | -2.6% |
| YoY Change | — | +151.8% | -52.3% | -122.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.